AB 526 — Dentists and podiatrists: clinical laboratories and vaccines.

Summary

Existing law provides for the certification and regulation of podiatrists by the Podiatric Medical Board of California within the Department of Consumer Affairs. Under existing law, the certificate to practice podiatric medicine authorizes the holder to practice podiatric medicine and defines "podiatric medicine" to mean the diagnosis, medical, surgical, mechanical, manipulative, and electrical treatment of the human foot, including the ankle and tendons that insert into the foot and the nonsurgical treatment of the muscles and tendons of the leg governing the functions of the foot. Existing law, the Dental Practice Act, provides for the licensure and regulation of persons engaged in the practice of dentistry by the Dental Board of California. Existing law defines dentistry as the diagnosis or treatment, by surgery or other method, of diseases and lesions and the correction of malpositions of the human teeth, alveolar process, gums, jaws, or associated structures, and provides that diagnosis or treatment may include all necessary related procedures as well as the use of drugs, anesthetic agents, and physical evaluation. Existing law provides that a person practices dentistry if the person performs various specified acts. Existing law also provides for the registration and regulation of registered dental hygienists by the Dental Hygiene Board of California within the Department of Consumer Affairs. This bill would additionally authorize a dentist or podiatrist, if the dentist or podiatrist complies with specified requirements, to independently prescribe and administer influenza and COVID-19 vaccines approved or authorized by the United States Food and Drug Administration for persons 3 years of age or older, as specified. The bill would authorize the board to adopt regulations to implement these provisions, as provided. The bill would count vaccine training provided through the federal Centers for Disease Control and Prevention toward the fulfillment of a podiatrist's continuing education requirements, and would count vaccine training provided through the federal Centers for Disease Control and Prevention or the California Pharmacists Association toward the fulfillment of a dentist's or dental hygienist's continuing education requirements, as specified. Existing law provides for the licensure, registration, and regulation of clinical laboratories and various clinical laboratory personnel by the State Department of Public Health. Existing law requires a clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 to be performed under the overall operation and administration of a laboratory director, which is defined to include certain licensees. This bill would expand the definition of "laboratory director" to include a duly licensed dentist serving as the director of a laboratory that performs only authorized clinical laboratory tests, as specified. This bill would incorporate additional changes to Section 1209 of the Business and Professions Code proposed by SB 409 to be operative only if this bill and SB 409 are enacted and this bill is enacted last. This bill would declare that it is to take effect immediately as an urgency statute.

Bill Text

• Chaptered 10/08/21 - Chaptered Current pdf October 08, 2021
• Enrolled 09/10/21 - Enrolled pdf September 10, 2021
• Amended 09/01/21 - Amended Senate pdf September 01, 2021
• Amended 05/25/21 - Amended Senate pdf May 25, 2021
• Amended 04/06/21 - Amended Assembly pdf April 06, 2021
• Introduced 02/10/21 - Introduced pdf February 10, 2021
• AB526 View text html

Action History

1. October 08, 2021

   Chaptered by Secretary of State - Chapter 653, Statutes of 2021.

2. October 08, 2021

   Approved by the Governor.

3. September 15, 2021

   Enrolled and presented to the Governor at 5 p.m.

4. September 08, 2021

   Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 79. Noes 0. Page 2904.).

5. September 08, 2021

   Assembly Rule 77 suspended. (Ayes 59. Noes 17. Page 2875.)

6. September 07, 2021

   In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 9 pursuant to Assembly Rule 77.

7. September 07, 2021

   Read third time. Urgency clause adopted. Passed. Ordered to the Assembly. (Ayes 37. Noes 0. Page 2459.).

8. September 02, 2021

   Read second time. Ordered to third reading.

9. September 01, 2021

   Read third time and amended. Ordered to second reading.

10. August 17, 2021

    Read second time. Ordered to third reading.

11. August 16, 2021

    From committee: Be ordered to second reading pursuant to Senate Rule 28.8.

12. July 12, 2021

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 14. Noes 0.) (July 12). Re-referred to Com. on APPR.

13. May 25, 2021

    From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on B., P. & E.D.

14. May 19, 2021

    Referred to Com. on B., P. & E.D.

15. May 06, 2021

    In Senate. Read first time. To Com. on RLS. for assignment.

16. May 06, 2021

    Read third time. Urgency clause adopted. Passed. Ordered to the Senate. (Ayes 77. Noes 0. Page 1336.).

17. April 29, 2021

    Read second time. Ordered to Consent Calendar.

18. April 28, 2021

    From committee: Do pass. To Consent Calendar. (Ayes 16. Noes 0.) (April 28).

19. April 14, 2021

    From committee: Do pass and re-refer to Com. on APPR. (Ayes 18. Noes 0.) (April 13). Re-referred to Com. on APPR.

20. April 07, 2021

    Re-referred to Com. on B. & P.

21. April 06, 2021

    From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended.

22. February 18, 2021

    Referred to Com. on B. & P.

23. February 11, 2021

    From printer. May be heard in committee March 13.

24. February 10, 2021

    Read first time. To print.

Sponsors

• Wood · Primary

Votes

Subjects